Crossmark

Microbial modulation of cardiovascular disease

Crossref DOI link: https://doi.org/10.1038/nrmicro.2017.149

Published Online: 2018-01-08

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Brown, J. Mark

Hazen, Stanley L.
License Information

Text and Data Mining valid from 2018-01-08
More Information

Article History

First Online: 8 January 2018

Competing interests

: S.L.H. is named as inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. He is also a paid consultant for P&G and has received research funds from Astra Zeneca, P&G, Pfizer Inc., Roche Diagnostics and Takeda. S.L.H. has also received royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland HeartLab, Esperion and Siemens. J.M.B. declares no competing interests.